Abstract Background Endometrial cancer is the most common gynecological malignancy; however. there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2). a biomarker of ovarian cancer. https://www.truvisionhealthftp.com/